Browse Category

Solutions - Page 16

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Alvotech plant issues foil another FDA review, this time for Teva-partnered Simponi biosimilar

Patients hoping to get their hands on a cheaper copycat of Johnson & Johnson’s fading anti-inflammatory blockbuster Simponi may have to wait for a few months more, thanks to an FDA inspection

November 3, 2025

News·Solutions

Lilly’s global manufacturing blitz rolls on with $3B plant in Netherlands, plans for 500 hires

Eli Lilly is allotting $3 billion to establish an oral medicines manufacturing facility in Katwijk, the Netherlands, the company said on Monday.

November 3, 2025

News·Solutions

CSL Seqirus strikes flu shot supply, production pact with Saudi Arabia

CSL Seqirus, the vaccine unit of Australian biotech CSL, signed a pact to provide Saudi Arabia with cell-based influenza shots and to help establish its production in-country. The move comes as part

October 30, 2025

News·Solutions

Lilly earmarks $1.2B for upgrades to Puerto Rico plant to boost oral drug production capacity

Eli Lilly has revealed a plan to spend $1.2 billion to upgrade its plant in Carolina, Puerto Rico. The investment will add 100 manufacturing jobs and bolster the company’s capacity to produce

October 29, 2025

News·Solutions

Beyond Batteries: The Urgent Case for RF-Powered Medical Devices in Modern Healthcare

Healthcare facilities across America are grappling with a sustainability crisis hiding in plain sight. While hospitals focus on reducing carbon emissions and implementing green initiatives, a staggering waste stream continues to flow

October 28, 2025

Solutions

Regeneron reports another manufacturing-related rejection for Eylea HD, but says help is on the way

The FDA has issued another complete response letter to Regeneron over its high-dose Eylea due to unresolved issues at a Novo Nordisk manufacturing plant. The company, however, is making progress in lining

October 28, 2025

News·Solutions

Birds, lizards and cats, oh my: FDA blasts generic drug maker Hetero in scathing Form 483

The FDA slammed generics maker Hetero with a Form 483 after an inspection of one of its warehouses in India uncovered flying birds, skittering lizards and roaming cats, among a host of

October 28, 2025

News·Solutions

As Novo buyout anniversary nears, CDMO Catalent refines brand to highlight ‘missions that matter’

CDMO Catalent has unveiled a new corporate brand, which keeps the company’s moniker the same while trading in the simple blue-against-white lettering of its previous logo with a pair of intersecting, speech

October 27, 2025

News·Solutions

Lonza’s recently purchased Calif. biologics site plays key role in sales rebound

The company expects sales in the second half of the year to outpace those from the first and reiterated its annual revenue guidance, projecting growth between 20% and 21% for all of

October 23, 2025

News·Solutions

With Nemluvio sales booming, Galderma pledges to spend $650M on US-based manufacturing

Dermatology specialist Galderma has hopped on the U.S. manufacturing bandwagon, revealing a commitment to spend more than $650 million through 2030 as it taps domestic contractors to produce newly approved Nemluvio and

October 23, 2025

News·Solutions

Previous 1 … 14 15 16 17 18 … 20 Next

Go toTop